|
| Home : Long-lasting Chlorine Dioxide (ClO2) Aqueous Solution Presented by Taiko Pharmaceutical and Kitasato University Inactivates over 99.99% of SARS-CoV-2 (COVID-19 Virus) |
|
Jun 11
2021 |
Long-lasting Chlorine Dioxide (ClO2) Aqueous Solution Presented by Taiko Pharmaceutical and Kitasato University Inactivates over 99.99% of SARS-CoV-2 (COVID-19 Virus) |
|
OSAKA, Japan, June 11, 2021 /PRNewswire/ -- Taiko Pharmaceutical Co., Ltd. based in Osaka, Japan, hereby announced that long-lasting chlorine dioxide (ClO2) aqueous solution (*1) inactivated over 99.99% of SARS-CoV-2 (COVID-19 Virus), including its Alpha and Gamma variants (*2), in a test... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/long-lasting-chlorine-dioxide-clo2-aqueous-solution-presented-by-taiko-pharmaceutical-and-kitasato-university-inactivates-over-99-99-of-sars-cov-2-covid-19-virus-301310684.html |
| |
|
Related News
|
» Risen Energy Unveils NewT@N at SNEC 2021, the Industry's First Mass-Produced 700W High-Efficiency Power Module
» SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TLND, ALTA, XOG, AMRB; Shareholders are Encouraged to Contact the Firm
|
|
|
